These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32886351)

  • 1. Impact of the isoelectric point of model parvoviruses on viral retention in anion-exchange chromatography.
    Leisi R; Wolfisberg R; Nowak T; Caliaro O; Hemmerle A; Roth NJ; Ros C
    Biotechnol Bioeng; 2021 Jan; 118(1):116-129. PubMed ID: 32886351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of virus-antibody interactions on viral clearance in anion exchange chromatography.
    Hung J; Lam SF; Tan Z; Choy D; Chennamsetty N; Lewandowski A; Qi W; Lynch M; Ghose S; Li ZJ
    J Chromatogr A; 2020 Dec; 1633():461635. PubMed ID: 33128974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic modeling of minute virus of mice surrogate removal by anion exchange chromatography in micro scale.
    Döring L; Winderl J; Kron M; Hubbuch J
    J Chromatogr A; 2024 Oct; 1734():465261. PubMed ID: 39216284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention of an anomalous chromatographic behavior and the resulting successful removal of viruses from monoclonal antibody with an asymmetric charge distribution by using a membrane adsorber in highly efficient, anion-exchange chromatography in flow-through mode.
    Masuda Y; Ogino Y; Yamaichi K; Takahashi Y; Nonaka K; Wakamatsu K
    Biotechnol Prog; 2020 May; 36(3):e2955. PubMed ID: 31894893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective Evaluation of Cycled Resin in Viral Clearance Studies-A Multiple Company Collaboration.
    Mattila J; Curtis S; Webb-Vargas Y; Wilson E; Galperina O; Roush D; Tobler S; Stanley B; Clark M; Weaver J; Pike J; Yu D; Li X; Flicker A; Kindermann J; Schuelke N; Whitcombe R; Bennett L
    PDA J Pharm Sci Technol; 2019; 73(5):470-486. PubMed ID: 31101706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a noninfectious MVM surrogate for assessing viral clearance during downstream process development.
    Orchard JD; Cetlin D; Pallansch M; Barlow R; Borman J; Dhar A; Pallansch L; Dickson M
    Biotechnol Prog; 2020 Jan; 36(1):e2921. PubMed ID: 31587529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into viral clearance during the chromatography steps in antibody processes by using virus surrogates.
    Dyer R; Song Y; Chen J; Bigelow E; McGinnis J; Jenkins L; Ghose S; Li ZJ
    Biotechnol Prog; 2020 Nov; 36(6):e3057. PubMed ID: 33405373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Non-Infectious Virus-Like Particle Surrogates for Viral Clearance Applications.
    Johnson S; Brorson KA; Frey DD; Dhar AK; Cetlin DA
    Appl Biochem Biotechnol; 2017 Sep; 183(1):318-331. PubMed ID: 28281181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.
    Grueso E; Sánchez-Martínez C; Calvo-López T; de Miguel FJ; Blanco-Menéndez N; Fernandez-Estevez M; Elizalde M; Sanchez J; Kourani O; Martin D; Tato A; Guerra M; Andrés G; Almendral JM
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anion exchange membrane adsorbers for flow-through polishing steps: Part I. Clearance of minute virus of mice.
    Weaver J; Husson SM; Murphy L; Wickramasinghe SR
    Biotechnol Bioeng; 2013 Feb; 110(2):491-9. PubMed ID: 22949170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting robustness of anion exchange chromatography: Selective retention of minute virus of mice using membrane media.
    Chen ST; Xu W; Cai K; Ferreira G; Ranil Wickramasinghe S; Qian X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1210():123449. PubMed ID: 36148766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a modular virus clearance package for anion exchange chromatography operated in weak partitioning mode.
    Iskra T; Sacramo A; Gallo C; Godavarti R; Chen S; Lute S; Brorson K
    Biotechnol Prog; 2015; 31(3):750-7. PubMed ID: 25826186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings of the 2019 Viral Clearance Symposium, Session 2: New Modalities in Chromatography and Adsorptive Filters.
    Specht R; Schwantes A
    PDA J Pharm Sci Technol; 2022; 76(4):306-314. PubMed ID: 34911828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles.
    Leuchs B; Frehtman V; Riese M; Müller M; Rommelaere J
    Appl Microbiol Biotechnol; 2017 Apr; 101(8):3143-3152. PubMed ID: 28091791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus removal robustness of ion exchange chromatography.
    Cai K; Anderson J; Orchard JD; Afdahl CD; Dickson M; Li Y
    Biologicals; 2019 Mar; 58():28-34. PubMed ID: 30661901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anion exchange membrane adsorbers for flow-through polishing steps: Part II. Virus, host cell protein, DNA clearance, and antibody recovery.
    Weaver J; Husson SM; Murphy L; Wickramasinghe SR
    Biotechnol Bioeng; 2013 Feb; 110(2):500-10. PubMed ID: 22951992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations-Purification Unit Operations.
    Roush D; Kreil TR
    PDA J Pharm Sci Technol; 2018; 72(5):479-487. PubMed ID: 30030354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies.
    Gefroh E; Dehghani H; McClure M; Connell-Crowley L; Vedantham G
    PDA J Pharm Sci Technol; 2014; 68(3):297-311. PubMed ID: 25188350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics.
    Strauss DM; Lute S; Tebaykina Z; Frey DD; Ho C; Blank GS; Brorson K; Chen Q; Yang B
    Biotechnol Bioeng; 2009 Oct; 104(2):371-80. PubMed ID: 19575414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resin and loading condition screening for effective and robust byproducts removal by anion exchange chromatography: A case study.
    Chen W; Wang PK; Liao CC; Li Y; Wan Y
    Protein Expr Purif; 2023 Oct; 210():106297. PubMed ID: 37209930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.